Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGSWW) Return on Equity (2021 - 2025)

GeneDx Holdings has reported Return on Equity over the past 5 years, most recently at 0.07% for Q4 2025.

  • Quarterly results put Return on Equity at 0.07% for Q4 2025, up 16.0% from a year ago — trailing twelve months through Dec 2025 was 0.07% (up 16.0% YoY), and the annual figure for FY2025 was 0.08%, up 14.0%.
  • Return on Equity for Q4 2025 was 0.07% at GeneDx Holdings, down from 0.01% in the prior quarter.
  • Over the last five years, Return on Equity for WGSWW hit a ceiling of 2.79% in Q3 2021 and a floor of 1.83% in Q1 2023.
  • Median Return on Equity over the past 5 years was 0.39% (2024), compared with a mean of 0.34%.
  • Biggest five-year swings in Return on Equity: crashed -326bps in 2022 and later surged 125bps in 2024.
  • GeneDx Holdings' Return on Equity stood at 0.63% in 2021, then plummeted by -114bps to 1.35% in 2022, then soared by 46bps to 0.73% in 2023, then skyrocketed by 68bps to 0.23% in 2024, then surged by 70bps to 0.07% in 2025.
  • The last three reported values for Return on Equity were 0.07% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025) per Business Quant data.